Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1482065Generated: October 30, 2026

Methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate → Methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate

https://huagongshe.com/reaction/1482065

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMethyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetateHCID 118308795—
ReactantMethyl 2-(2-(3-bromophenyl)-5-chloro-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetateHCID 118308831—
ProductMethyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetateHCID 11830884860%

Reaction Steps

Prepared from methyl 2-(2-(3-bromophenyl)-5-chloro-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate in 60% yield following the same procedure as methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate. LCMS (ESI, M+1): 540.20.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09409922B2
Source datasetuspto-grants-2016_08
ORD IDord-d2ca2d0cbd6c4c0ba76179dc1e73e155
Source noteuspto-grants-2016_08